Magellan®: Clinical Trials

3 trials of Magellan®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1

Follow Magellan®: new trials by email Literature Review of Magellan® trials Research Report on Magellan®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns
Magellan®, Placebo Saline Gel and Usual and Customary Standard of Care - Acute Burns
Phase 1UnknownArteriocyte, Inc.422013-04-012018-01-09
Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
Magellan® - Compartment Syndrome
Phase 1CompletedArteriocyte, Inc.52013-01-012017-04-13
Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)
Magellan® - Critical Limb Ischemia (CLI), Peripheral Vascular Disease (PVD)
Phase 1CompletedArteriocyte, Inc.182011-04-012017-01-24

Conditions studied

Chronic Limb-Threatening Ischemia (1)  ·  Compartment Syndromes (1)  ·  Peripheral Vascular Diseases (1)  ·  Wounds and Injuries (1)

Sponsors

Arteriocyte, Inc. (3)

Countries

United States (3)

Top investigators

Brian Barnes, PhD (1)  ·  Brian R. Barnes, PhD (1)  ·  Michael Go, MD (1)